NASP Submits Comments on Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

In comments on CMS’s proposed GUARD Model for Medicare Part D, NASP cautioned that the international reference pricing and rebate structure could disrupt specialty pharmacy services and patient access. Click here to read the full comments.